DK1071704T3 - Nye matrix metalloproteinasehæmmere og nedregulatorer - Google Patents

Nye matrix metalloproteinasehæmmere og nedregulatorer

Info

Publication number
DK1071704T3
DK1071704T3 DK99910394T DK99910394T DK1071704T3 DK 1071704 T3 DK1071704 T3 DK 1071704T3 DK 99910394 T DK99910394 T DK 99910394T DK 99910394 T DK99910394 T DK 99910394T DK 1071704 T3 DK1071704 T3 DK 1071704T3
Authority
DK
Denmark
Prior art keywords
inhibitors
regulators
mmp
matrix metalloproteinase
novel
Prior art date
Application number
DK99910394T
Other languages
English (en)
Inventor
Erkki Koivunen
Timo Sorsa
Tuula Salo
Original Assignee
Ctt Cancer Targeting Tech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctt Cancer Targeting Tech Oy filed Critical Ctt Cancer Targeting Tech Oy
Application granted granted Critical
Publication of DK1071704T3 publication Critical patent/DK1071704T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99910394T 1998-03-18 1999-03-17 Nye matrix metalloproteinasehæmmere og nedregulatorer DK1071704T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980604A FI980604A0 (fi) 1998-03-18 1998-03-18 Nya matrismetalloproteinasinhibitorer och -regulatorer
PCT/FI1999/000204 WO1999047550A1 (en) 1998-03-18 1999-03-17 Novel matrix metalloproteinase inhibitors and down-regulators

Publications (1)

Publication Number Publication Date
DK1071704T3 true DK1071704T3 (da) 2003-10-20

Family

ID=8551311

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99910394T DK1071704T3 (da) 1998-03-18 1999-03-17 Nye matrix metalloproteinasehæmmere og nedregulatorer

Country Status (12)

Country Link
US (1) US6624144B1 (da)
EP (1) EP1071704B1 (da)
JP (1) JP2002506881A (da)
AT (1) ATE243709T1 (da)
AU (1) AU2936599A (da)
CA (1) CA2323239C (da)
DE (1) DE69909076T2 (da)
DK (1) DK1071704T3 (da)
ES (1) ES2203088T3 (da)
FI (1) FI980604A0 (da)
PT (1) PT1071704E (da)
WO (1) WO1999047550A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9907908D0 (en) * 1999-04-07 1999-06-02 Bataille Regis Organic compounds
DE10020447A1 (de) * 2000-03-31 2001-10-11 Henkel Kgaa Verwendung von Protease-Inhibitoren in der Kosmetik und Pharmazie
EP1174129A1 (en) * 2000-07-17 2002-01-23 Zenner, Hans Peter, Prof. Dr. med. Use of a matrix-metalloprotease inhibitor for the treatment of cancer
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
FI113840B (fi) * 2001-03-26 2004-06-30 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
WO2003053447A1 (en) * 2001-12-20 2003-07-03 Hanauske-Abel Hartmut M Treatment for averting or delaying premature delivery
CN101993907B (zh) * 2002-01-08 2018-12-28 迈克尔·R·拉尔布 表达civps或内含肽修饰蛋白的转基因植物及其制备方法
US20040224378A1 (en) * 2002-06-07 2004-11-11 Athersys, Inc. Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs
FI20021726A0 (fi) * 2002-09-27 2002-09-27 Ctt Cancer Targeting Tech Oy Menetelmä peptidien tuottamiseksi
CN1314704C (zh) * 2002-11-20 2007-05-09 中国人民解放军军事医学科学院放射与辐射医学研究所 基质金属蛋白酶2的小肽抑制剂
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2004089294A2 (en) 2003-04-04 2004-10-21 Incyte Corporation Compositions, methods and kits relating to her-2 cleavage
WO2005019247A2 (en) * 2003-08-15 2005-03-03 Board Of Regents, The University Of Texas System Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
FR2932182A1 (fr) * 2008-06-10 2009-12-11 Commissariat Energie Atomique Cyclopeptides utilisables en tant qu'inhibiteurs d'enzymes proteases du type mmp
KR101363455B1 (ko) 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도
CN108484729B (zh) * 2018-03-23 2019-09-17 中国药科大学 一种基质金属蛋白酶9的多肽抑制剂及其应用
CN121943786A (zh) * 2025-12-26 2026-05-01 广东医科大学 一种集成多肽药物的胶原凝胶递送体系及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666897A (en) 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
JP3787605B2 (ja) * 1994-10-05 2006-06-21 ダーウィン・ディスカバリー・リミテッド ペプチジル化合物および金属プロテアーゼのインヒビターとしてのその治療的使用
US5652227A (en) 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals

Also Published As

Publication number Publication date
PT1071704E (pt) 2003-11-28
EP1071704A1 (en) 2001-01-31
AU2936599A (en) 1999-10-11
CA2323239A1 (en) 1999-09-23
DE69909076D1 (de) 2003-07-31
CA2323239C (en) 2008-04-15
JP2002506881A (ja) 2002-03-05
EP1071704B1 (en) 2003-06-25
ATE243709T1 (de) 2003-07-15
US6624144B1 (en) 2003-09-23
FI980604A0 (fi) 1998-03-18
WO1999047550A1 (en) 1999-09-23
ES2203088T3 (es) 2004-04-01
DE69909076T2 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
FI980604A0 (fi) Nya matrismetalloproteinasinhibitorer och -regulatorer
Shankavaram et al. Monocyte membrane type 1-matrix metalloproteinase: prostaglandin-dependent regulation and role in metalloproteinase-2 activation
NO963499L (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
BR0308967A (pt) Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação
DE69433647D1 (de) Menschliche proteaseinhibitoren vom kunitztyp
PT1261600E (pt) Derivados heteroaromaticos de carboxamida e sua utilizacao como inibidores do enzima ikk-2
BR0200782A (pt) Compostos para o tratamento da isquemia
NO972538D0 (no) Nye sulfonamider
ES2193949T3 (es) Nuevos derivados del acido lipoico, su preparacion y composiciones farmaceuticas que los contienen.
NO306614B1 (no) Derivater i vitamin D-serien modifisert ved 20-stilling, mellomprodukter anvendt ved fremstilling av disse, farmasöytiske preparater inneholdende derivatene og deres anvendelse ved fremstilling av legemidler
BR0109780A (pt) Soluções de ácido ascórbico estabilizadas; uso das mesmas; processo para sua obtenção e formulações compreendendo as mesmas
ATE330601T1 (de) Sulfonamide als matrix-metalloproteinase inhibitoren
BR0211641A (pt) Compostos anti-envelhecimento e de cura de ferimento
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
NO20000784L (no) Nye aggrecanaseinhibitorer og matriksmetalloproteinaser for behandling av artritt
AU7934900A (en) Method of screening for inhibitors of asp2
Song et al. Inhibitory effect of procyanidin oligomer from elm cortex on the matrix metalloproteinases and proteases of periodontopathogens
ATE253359T1 (de) Antithrombotische mittel
PT975588E (pt) Compostos antipicornavirais, composicoes que os contem e metodos para a sua utilizacao
PT817624E (pt) Inibidores de proteases de parasitas metazoarios
MEP16708A (en) Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
BRPI0415885A (pt) ácidos piperidinil-e piperazinil-sulfonilmetilidroxámicos e sua utilização como inibidores de protease
DE69828522D1 (de) Antithrombotische mittel
Nakamura et al. 4-Methylumbelliferone induces the expression of membrane type 1-matrix metalloproteinase in cultured human skin fibroblasts
BRPI0511323A (pt) tetraidroisoquinolinas substituìdas usadas na forma de inibidores de mmp, método para a produção e uso das mesmas na forma de drágeas